clinical trial · NCT05590715
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
Autism Spectrum Disorder
brief summary
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
started
Oct 13, 2022
primary completion
Dec 31, 2025
completion
Dec 31, 2025
last updated
Jun 17, 2025
official title
International, Multicentric, Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol